133 Argatroban Use in Therapeutic Plasma Exchange (TPE): A Case of Dynamic Anticoagulation Response
Background: Therapeutic Plasma Exchange (TPE) removes circulating autoantibodies, immune complexes, and other pathogenic substances. TPE also removes circulating coagulation factors including thrombin. Warfarin can be used during TPE, but the anticoagulant effect may be increased. There is little evidence surrounding other anticoagulants. This is the first documented case reviewing the impact of TPE on concomitant argatroban, a direct thrombin inhibitor.
Authors
- Jennifer E. Stanton
- Alexander R. Nixon
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1016/j.rpth.2025.102779
- Citations
- 1
- Primary Topic
- Heparin-Induced Thrombocytopenia and Thrombosis
- Type
- article
- Field-Weighted Citation Impact
- 2.01